4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-(trideuteriomethoxy)benzamide;hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

24 API Suppliers, 9 USDMF, 4 CEP/COS, 1 JDMF, 3 EU WC, 8 NDC API, 15 Listed Suppliers

DEVELOPMENTS

18 Drugs in Development

18 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

146 FDF Dossiers, 78 FDA Orange Book, 35 Europe, 10 Canada, 4 South Africa, 19 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 5 Evonik, 5 Rochem International Inc, 18 SPI Pharma, 5 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 Kirsch Pharma, 1 Cerata Pharmaceuticals LLP, 5 Dr. Paul Lohmann GmbH & Co. KGaA, 4 ACG Worldwide, 6 Actylis, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 17 BASF, 1 CD Formulation, 2 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 1 Ideal Cures, 4 Ingredion Pharma Solutions, 1 JJ Chemicals, 15 Kerry, 2 Keval Exports, 3 Lonza Capsugel, 16 Microlex e.U, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Pharmachem, 1 Qualicaps, 28 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Silverline Chemicals, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

69 Fillers, Diluents & Binders, 41 Direct Compression, 34 Disintegrants & Superdisintegrants, 30 Taste Masking, 28 Granulation, 21 Chewable & Orodispersible Aids, 21 Thickeners and Stabilizers, 20 Parenteral, 19 Film Formers & Plasticizers, 14 Lubricants & Glidants, 13 Co-Processed Excipients, 11 Coating Systems & Additives, 11 Solubilizers, 8 Empty Capsules, 7 Controlled & Modified Release, 7 Topical, 5 Emulsifying Agents, 5 API Stability Enhancers, 1 Rheology Modifiers, 1 Soft Gelatin

DIGITAL CONTENT

2 News #PharmaBuzz

2 News #PharmaBuzz

GLOBAL SALES INFORMATION

13 US Medicaid Prescriptions, 5 Regulatory FDF Prices

MARKET PLACE

13 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

7 US Patents

7 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM

1 EDQM

Xls

Filters

4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-(trideuteriomethoxy)benzamide;hydrochloride

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Roquette

filter Capability Reset all filters

filter Country Reset all filters

01

Roquette

LYCAGEL

PEGS Boston Summit

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Looking for 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-(trideuteriomethoxy)benzamide;hydrochloride? Find Soft Gelatin used in 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-(trideuteriomethoxy)benzamide;hydrochloride to address drug delivery challenges on PharmaCompass.

4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-(trideuteriomethoxy)benzamide;hydrochloride

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

24 API Suppliers

9 USDMF

4 CEP/COS

1 JDMF

3 EU WC

8 NDC API

15 Listed Suppliers

DEVELOPMENTS

18 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

146 FDF Dossiers

78 FDA Orange Book

35 Europe

10 Canada

4 South Africa

19 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, ORALLY DISINTEGRATING;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

5 Evonik

5 Rochem International Inc

18 SPI Pharma

5 Boai NKY Pharmaceuticals Ltd

7 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 Pfanstiehl

4 Kirsch Pharma

1 Cerata Pharmaceuticals LLP

5 Dr. Paul Lohmann GmbH & Co. KGaA

4 ACG Worldwide

6 Actylis

1 Alcedo Pharmachem

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

17 BASF

1 CD Formulation

2 Corel Pharma Chem

6 DFE Pharma

1 Finar

7 Gangwal Chemicals

1 Ideal Cures

4 Ingredion Pharma Solutions

1 JJ Chemicals

15 Kerry

2 Keval Exports

3 Lonza Capsugel

16 Microlex e.U

1 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

2 Novo Excipients

4 Pharmatrans-Sanaq

6 Pluviaendo

3 Prachin Pharmachem

1 Qualicaps

28 Roquette

1 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

9 Sigachi Industries

3 Silverline Chemicals

1 Ulanqab Kema New Material

2 Valens Pharmachem

3 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

69 Fillers, Diluents & Binders

41 Direct Compression

34 Disintegrants & Superdisintegrants

30 Taste Masking

INJECTABLE;INJECTION - EQ 5MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, ORALLY DISINTEGRATING;ORAL - EQ 10MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons